News from September 2022

‘Truly remarkable drug’ helps motor neurone disease patients

30 Sep 22 - • A Phase 3 clinical trial of the investigational drug tofersen in patients with MND caused by the faulty SOD1 gene, has shown it can slow and reduce progression of the disease